Understanding Balance Impairment in COPD
An Investigation of the Physiological and Psychosocial Mechanisms Underpinning Balance Impairment in People With Chronic Obstructive Pulmonary Disease
2 other identifiers
observational
40
1 country
1
Brief Summary
This study is an observational study investigating the mechanisms of balance problems in people with COPD and how COPD impacts them living their daily lives. The main objectives of this study are:
- To quantify the relationship between balance and aspects of neuromuscular function in individuals with COPD, and compared to age-matched healthy controls
- To understand the lived experience of people with COPD and their carers Participants will attend an appointment at the University rehab lab to:
- Complete a balance test
- Fill out some questionnaires on mood, health status and balance and falls
- Complete some walking tests
- Have their body composition measured
- Have the function and strength of their leg nerves and muscles tested Researchers will compare people with COPD and healthy controls (older adults without COPD or other conditions known to impact balance) to see if any of the things measured are impacting the balance of people with COPD more than their peers without COPD.
- For 10 people with COPD only they will be visited at home to observe how they carry out everyday tasks and 5 of those 10 will have a follow up interview. Researchers will take notes and record interviews and look for similarities and interesting points in the notes and transcripts of the interviews to build a picture of what living with COPD is like.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 17, 2023
CompletedFirst Submitted
Initial submission to the registry
July 21, 2023
CompletedFirst Posted
Study publicly available on registry
August 9, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2024
CompletedAugust 9, 2023
August 1, 2023
10 months
July 21, 2023
August 8, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Balance Evaluation Systems Test (BESTest)
27 functional tasks scored on a 0-3 scale to give an overall percentage out from a maximum of 108 points. Higher scores indicate better balance.
baseline only
Secondary Outcomes (17)
The Activities- Specific Balance Confidence Scale (ABC)
baseline only
The Elderly Falls Screening Test
baseline only
Incremental Shuttle Walk Test
baseline only
COPD Assessment Test
baseline only
Medical Research Council Dyspnoea Scale
baseline only
- +12 more secondary outcomes
Study Arms (2)
COPD group
People with a spirometry confirmed diagnosis of Chronic Obstructive Pulmonary Disease (COPD)
Healthy Controls
Older adults over the age of 55 who do not have COPD
Eligibility Criteria
People living with COPD and people without COPD living in community settings in the North East of England, UK
You may qualify if:
- COPD
- Have a spirometry confirmed diagnosis of COPD as per GOLD guidelines
- Stable COPD (six weeks clear of exacerbation)
- years or over at the point of recruitment
- Able to communicate with good verbal English or use adaptive equipment to communicate
- Male or female Controls
- Free from a diagnosis of COPD (confirmed by spirometry)
- years or over at the point of recruitment
- Able to communicate with good verbal English or use adaptive equipment to
- Communicate
- Male or female
You may not qualify if:
- COPD
- Recent exacerbation of COPD (within the last six weeks)
- Under 55 years of age at the point of recruitment
- Any neurological or musculoskeletal diagnoses (e.g., strokes, Parkinson's disease or chronic pain that interferes with ability to safely complete the tests
- Unable to provide written informed consent
- Unable to speak English or no translation options available
- Diagnosed but not corrected visual, vestibular disturbance and peripheral neuropathy
- Vasovagal syncope
- Not independent living (e.g., living in a care home or prison) Controls
- Abnormal lung function (FEV1 and FVC equal to or greater than 80% and FEV1/FVC equal to greater than 70%)
- Under 55 years of age at the point of recruitment
- Any neurological or musculoskeletal impairment that would significantly affect balance impacting ability to safely complete the assessments
- Unable to provide written informed consent
- Unable to speak English or no translation options available
- Any uncorrected visual or somatosensory disturbance
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Teesside University
Middlesbrough, TS1 3BX, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Samantha L Harrison, PhD
Teesside University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Respiratory Rehabilitation
Study Record Dates
First Submitted
July 21, 2023
First Posted
August 9, 2023
Study Start
July 17, 2023
Primary Completion
May 1, 2024
Study Completion
May 1, 2024
Last Updated
August 9, 2023
Record last verified: 2023-08